Clinical Trial Update: An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment

View source ↗

Summary

An observational study in China assesses the efficacy and safety of darolutamide in combination with androgen deprivation therapy for men with non-metastatic ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-metastatic Castration-resistant Prostate Cancer

Drugs mentioned

• Darolutamide (darolutamide)

Snippet

Sponsor: Bayer | Conditions: Non-metastatic Castration-resistant Prostate Cancer | Status: NOT_YET_RECRUITING